New England Cancer Specialists

Summary

New England Cancer Specialists is a medical facility located in Scarborough, Maine. This center is recognized for care of Breast Cancer, Non-Small Cell Lung Cancer, Lung Cancer, Cancer, Pancreatic Cancer and other specialties. New England Cancer Specialists is involved with conducting 54 clinical trials across 59 conditions. There are 2 research doctors associated with this hospital, such as Chiara Battelli, MD and John P Winters, III, MD.

Top PIs

Clinical Trials running at New England Cancer Specialists

Breast Cancer

Chronic Lymphocytic Leukemia

Lung Cancer

Lymphoma

Parkinson's disease

Solid Tumors

CLL

Giredestrant vs. Fulvestrant

for Advanced Breast Cancer

This trial is testing two drug combinations to treat a specific type of advanced breast cancer that no longer responds to standard hormone treatments. The goal is to see which combination works better by stopping the cancer cells from growing.

Recruiting

2 awards

Phase 3

8 criteria

Sacituzumab Govitecan + Pembrolizumab

for Triple Negative Breast Cancer

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.

Recruiting

2 awards

Phase 3

6 criteria

T-DM1 vs TH

for Breast Cancer

This research study is studying how well newly diagnosed breast cancer that has tested positive for a protein called HER2 responds using one of two different combination of HER2-directed therapies as a treatment after surgery. The name of the study drugs involved are: * Trastuzumab-emtansine (T-DM1, Kadcyla) * Trastuzumab SC (Herceptin Hylecta) * Paclitaxel

Recruiting

1 award

Phase 2